Calypte Biomedical Corp (CBMC.PK)

HEALTH CARE: PHARMACEUTICALS
SIC: LABORATORY ANALYTICAL INSTRUMENTS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

5000 HOPYARD ROAD, SUITE 480 PLEASANTON, CA 94588

Calypte Biomedical develops, manufactures, and distributes in vitro diagnostic tests, primarily for the diagnosis of Human Immunodeficiency Virus (HIV) infection. Co.'s principal focus is on commercializing its Aware HIV-1/2 Rapid Tests, test products for the rapid detection of antibodies to HIV-1 and HIV Type 2 (HIV-2) in oral fluid using a lateral flow dipstick design. In addition, Co.'s other Aware product line includes the HIV-1 BED Incidence EIA test, which detects HIV-1 infections that have occurred within approximately the prior six months; and the Aware Messenger oral fluid collection device that is used for the detection of specific antibodies or other substances.

View SEC Filings from CBMC.PK instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 595.888 Thousand 595.888 Thousand 0.0%
% Ownership
New Positions: 1
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBMC.PK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBMC.PK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EDILASHVILI KARTLOS

  • Director
0 2010-02-01 0

FREIMAN PAUL E

  • FORMER DIRECTOR
No longer subject to file 2009-09-10 0

KREVANS JULIUS R

  • FORMER DIRECTOR
No longer subject to file 2009-09-10 0

DIPIETRO JOHN J

  • FORMER DIRECTOR
No longer subject to file 2009-09-10 0

TAYLOR DONALD N PRESIDENT AND CHIEF EXECUTIVE

  • Officer
1,000,000 2008-07-28 0

GALE ROGER I PRESIDENT AND CEO

  • Officer
  • Director
12,072,275 2008-04-01 0

DOTSON JERROLD DUANE VP - FINANCE &ADMINISTRATION

  • Officer
0 2008-04-01 0

MINK RONALD WILLIAM CHIEF SCIENCE OFFICER

  • Officer
0 2008-04-01 0

SULAIMAN MOHAMED YOUSIF AHMED SALEH

  • 10% Owner
31,375,000 2008-03-03 0

AHMED MOHAMED

  • 10% Owner
32,375,000 2008-02-26 0

ALSUWAIDI AHMED ABDULLA DEEMAS

  • 10% Owner
33,920,000 2007-12-24 0

KHIDASHELI DAVID

  • 10% Owner
34,000,000 2007-12-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments